2025 ACA 155th Congress of Correction Denver_Planning Guide

Health Care Special Session & Luncheon

Seating is Limited!

Dr. Andrew Aronsohn Associate Professor of Medicine, Center for Liver Diseases UNIVERSITY OF CHICAGO MEDICAL CENTER

Monday, Aug. 25, 2025 • 12–1:30 p.m. • Four Seasons Ballroom 1

A ndrew Aronsohn is an Associate Professor of Medicine in the Center for Liver Diseases at the University of Chicago Medical Center. Dr. Aronsohn serves as the program director of the gastroenterology fellowship as well as the chief of hepatology. Dr. Aronsohn is the co-principal investigator of HepCCATT, an initiative to diagnose, link to care, and treat HCV in the Chicago area. This project utilizes telehealth technology to expand HCV management into the primary care setting. Dr. Aronsohn is a co-chair of the AASLD/IDSA HCV guidance and was a member of the National Academies of Medicine committee which wrote “A National Strategy for the Elimination of Hepatitis B and C.” He also has a busy clinical practice, which includes both general and transplant hepatology.

Plan to Attend!

Learning Objectives: • Introduce new Test and Treat Algorithm using Point of Care HCV RNA Testing. • Describe implementation of this approach in corrections. • Describe Barriers to the Test and Treat Approach: Cost, Implementation and Health Information Systems.

Supported by an independent medical education grant from Centurion.

46